Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis

Nav

General Info

Geography

Austria (AUT)

Canada (CAN)

Denmark (DNK)

France (FRA)

Germany (DEU)

Greece (GRC)

Iceland (ISL)

Italy (ITA)

Japan (JPN)

Netherlands (NLD)

Norway (NOR)

Republic of Korea (KOR)

Spain (ESP)

Sweden (SWE)

United Kingdom (GBR)

United States of America (USA)

View all

Time period covered

01/1961 - 12/2003

Data type

Scientific literature

Keywords

Body mass index, Corpus uteri cancer

Citation

Authors

Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG

Journal

Cancer Epidemiol Biomarkers Prev

Volume

Issue

Pages

3119–30

Publication year

2010

Suggested citation

Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010; 19(12): 3119–30.

GHDx Entry last modified on: May 28, 2019

Header sites

Search form

Main menu

Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis

Nav